Literature DB >> 17868493

Absolute bioavailability and dose-dependent pharmacokinetic behaviour of dietary doses of the chemopreventive isothiocyanate sulforaphane in rat.

Natalya Hanlon1, Nick Coldham, Adriana Gielbert, Nikolai Kuhnert, Maurice J Sauer, Laurie J King, Costas Ioannides.   

Abstract

Sulforaphane is a naturally occurring isothiocyanate with promising chemopreventive activity. An analytical method, utilising liquid chromatography-MS/MS, which allows the determination of sulforaphane in small volumes of rat plasma following exposure to low dietary doses, was developed and validated, and employed to determine its absolute bioavailability and pharmacokinetic characteristics. Rats were treated with either a single intravenous dose of sulforaphane (2.8 micromol/kg) or single oral doses of 2.8, 5.6 and 28 mumol/kg. Sulforaphane plasma concentrations were determined in blood samples withdrawn from the rat tail at regular time intervals. Following intravenous administration, the plasma profile of sulforaphane was best described by a two-compartment pharmacokinetic model, with a prolonged terminal phase. Sulforaphane was very well and rapidly absorbed and displayed an absolute bioavailability of 82 %, which, however, decreased at the higher doses, indicating a dose-dependent pharmacokinetic behaviour; similarly, Cmax values did not rise proportionately to the dose. At the highest dose used, the rate of absorption constant k(ab), biological half-life t(1/2) and apparent volume of distribution decreased significantly. It is concluded that in the rat orally administered sulforaphane is rapidly absorbed, achieving high absolute bioavailability at low dietary doses, but dose-dependent pharmacokinetics was evident, with bioavailability decreasing with increasing dose.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17868493     DOI: 10.1017/S0007114507824093

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  48 in total

1.  Hill coefficients of dietary polyphenolic enzyme inhibitiors: can beneficial health effects of dietary polyphenols be explained by allosteric enzyme denaturing?

Authors:  Nikolai Kuhnert; Farnoosh Dairpoosh; Rakesh Jaiswal; Marius Matei; Sagar Deshpande; Agnieszka Golon; Hany Nour; Hande Karaköse; Nadim Hourani
Journal:  J Chem Biol       Date:  2011-01-29

2.  Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington's disease.

Authors:  Yanying Liu; Casey L Hettinger; Dong Zhang; Khosrow Rezvani; Xuejun Wang; Hongmin Wang
Journal:  J Neurochem       Date:  2014-01-18       Impact factor: 5.372

3.  Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice.

Authors:  John D Clarke; Anna Hsu; David E Williams; Roderick H Dashwood; Jan F Stevens; Masayuki Yamamoto; Emily Ho
Journal:  Pharm Res       Date:  2011-06-17       Impact factor: 4.200

4.  Differential modulation of dibenzo[def,p]chrysene transplacental carcinogenesis: maternal diets rich in indole-3-carbinol versus sulforaphane.

Authors:  Lyndsey E Shorey; Erin P Madeen; Lauren L Atwell; Emily Ho; Christiane V Löhr; Clifford B Pereira; Roderick H Dashwood; David E Williams
Journal:  Toxicol Appl Pharmacol       Date:  2013-04-06       Impact factor: 4.219

Review 5.  Sulforaphane - role in aging and neurodegeneration.

Authors:  Roberto Santín-Márquez; Adriana Alarcón-Aguilar; Norma Edith López-Diazguerrero; Niki Chondrogianni; Mina Königsberg
Journal:  Geroscience       Date:  2019-04-02       Impact factor: 7.713

Review 6.  Isothiocyanates: Translating the Power of Plants to People.

Authors:  Dushani L Palliyaguru; Jian-Min Yuan; Thomas W Kensler; Jed W Fahey
Journal:  Mol Nutr Food Res       Date:  2018-03-26       Impact factor: 5.914

7.  Analysis of autophagic flux in response to sulforaphane in metastatic prostate cancer cells.

Authors:  Gregory W Watson; Samanthi Wickramasekara; Yufeng Fang; Zoraya Palomera-Sanchez; Claudia S Maier; David E Williams; Roderick H Dashwood; Viviana I Perez; Emily Ho
Journal:  Mol Nutr Food Res       Date:  2015-08-13       Impact factor: 5.914

8.  Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane.

Authors:  Olga Azarenko; Tatiana Okouneva; Keith W Singletary; Mary Ann Jordan; Leslie Wilson
Journal:  Carcinogenesis       Date:  2008-10-23       Impact factor: 4.944

9.  Loratadine self-microemulsifying drug delivery systems (SMEDDS) in combination with sulforaphane for the synergistic chemoprevention of pancreatic cancer.

Authors:  Preshita Desai; Arvind Thakkar; David Ann; Jeffrey Wang; Sunil Prabhu
Journal:  Drug Deliv Transl Res       Date:  2019-06       Impact factor: 4.617

10.  Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits.

Authors:  George S G Shehatou; Ghada M Suddek
Journal:  Exp Biol Med (Maywood)       Date:  2015-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.